Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beinaglutide versus biphasic insulin aspart 30 as add-on to metformin in type 2 diabetes
ChiCTR1900021970Phase 4Recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Oct 2017
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in type 2 diabetes mellitus (T2DM) comparing Beinaglutide plus metformin with Biphasic insulin aspart 30 plus metformin (2 arms). Primary endpoint: HbA1c. Started Oct 2017; status: recruiting.
02
Drugs
beinaglutideinsulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR1900021970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021970.